Barclays raised the firm’s price target on Corteva (CTVA) to $62 from $58 and keeps an Equal Weight rating on the shares. The company should start to see recovery in Latin America volumes, though offset by pricing, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA: